In general, placebo controlled trials are usually conducted for diseases which don't have an effective standard of care, or for conditions which aren't serious enough to be considered life threatening. For more serious diseases where a standard of care exists (standard of care is usually scientifically discovered but validated by placebo controlled trials), you conduct trials and compare the performance of the new drug/therapy with the existing standard of care as the control group.
More familiar than you apparently, because placebos have been proven to work:
https://www.medscape.com/viewarticle/853175
I think the problem is the subjective measure, so it's impossible to know which symptoms are caused by c.diff and which from IBS.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2647647/ for more.
Also, given that the placebo improvement rates are 40-90% in all c.diff trials, it would be unethical to not use a placebo arm.